Stanford investigators used high-throughput analysis to link inflammation to chronic fatigue syndrome, a difficult-to-diagnose disease with no known cure.
Researchers at the Stanford University School of Medicine have linked chronic fatigue syndrome to variations in 17 immune-system signaling proteins, or cytokines, whose concentrations in the blood correlate with the disease’s severity.
The findings provide evidence that inflammation is a powerful driver of this mysterious condition, whose underpinnings have eluded researchers for 35 years.
The findings, described in a study published online July 31 in the Proceedings of the National Academy of Sciences, could lead to further understanding of this condition and be used to improve the diagnosis and treatment of the disorder, which has been notably difficult.
More than 1 million people in the United States suffer from chronic fatigue syndrome, also known as myalgic encephomyelitis and designated by the acronym ME/CFS. It is a disease with no known cure or even reliably effective treatments. Three of every four ME/CFS patients are women, for reasons that are not understood. It characteristically arises in two major waves: among adolescents between the ages of 15 and 20, and in adults between 30 and 35. The condition typically persists for decades.
“Chronic fatigue syndrome can turn a life of productive activity into one of dependency and desolation,” said Jose Montoya, MD, professor of infectious diseases, who is the study’s lead author. Some spontaneous recoveries occur during the first year, he said, but rarely after the condition has persisted more than five years.
The study’s senior author is Mark Davis, PhD, professor of immunology and microbiology and director of Stanford’s Institute for Immunity, Transplantation and Infection.
‘Solid basis for a diagnostic blood test’
“There’s been a great deal of controversy and confusion surrounding ME/CFS — even whether it is an actual disease,” said Davis. “Our findings show clearly that it’s an inflammatory disease and provide a solid basis for a diagnostic blood test.”
any, but not all, ME/CFS patients experience flulike symptoms common in inflammation-driven diseases, Montoya said. But because its symptoms are so diffuse —sometimes manifesting as heart problems, sometimes as mental impairment nicknamed “brain fog,” other times as indigestion, diarrhea, constipation, muscle pain, tender lymph nodes and so forth — it often goes undiagnosed, even among patients who’ve visited a half-dozen or more different specialists in an effort to determine what’s wrong with them.
Montoya, who oversees the Stanford ME/CFS Initiative, came across his first ME/CFS patient in 2004, an experience he said he’s never forgotten.
“I have seen the horrors of this disease, multiplied by hundreds of patients,” he said. “It’s been observed and talked about for 35 years now, sometimes with the onus of being described as a psychological condition. But chronic fatigue syndrome is by no means a figment of the imagination. This is real.”
Antivirals, anti-inflammatories and immune-modulating drugs have led to symptomatic improvement in some cases, Montoya said. But no single pathogenic agent that can be fingered as the ultimate ME/CFS trigger has yet been isolated, while previous efforts to identify immunological abnormalities behind the disease have met with conflicting and confusing results.
Still, the sporadic effectiveness of antiviral and anti-inflammatory drugs has spurred Montoya to undertake a systematic study to see if the inflammation that’s been a will-o’-the-wisp in those previous searches could be definitively pinned down.
To attack this problem, he called on Davis, who helped create the Human Immune Monitoring Center. Since its inception a decade ago, the center has served as an engine for large-scale, data-intensive immunological analysis of human blood and tissue samples. Directed by study co-author Holden Maecker, PhD, a professor of microbiology and immunology, the center is equipped to rapidly assess gene variations and activity levels, frequencies of numerous immune cell types, blood concentrations of scores of immune proteins, activation states of intercellular signaling models, and more on a massive scale.
Finding patterns
This approach is akin to being able to look for and find larger patterns — analogous to whole words or sentences — in order to locate a desired paragraph in a lengthy manuscript, rather than just try to locate it by counting the number of times in which the letter A appears in every paragraph.
The scientists analyzed blood samples from 192 of Montoya’s patients, as well as from 392 healthy control subjects. The average age of patients and controls was about 50. Patients’ average duration of symptoms was somewhat more than 10 years.
Importantly, the study design took into account patients’ disease severity and duration. The scientists found that some cytokine levels were lower in patients with mild forms of ME/CFS than in the control subjects, but elevated in ME/CFS patients with relatively severe manifestations. Averaging the results for patients versus controls with respect to these measures would have obscured this phenomenon, which Montoya said he thinks may reflect different genetic predispositions, among patients, to progress to mild versus severe disease.
I have seen the horrors of this disease, multiplied by hundreds of patients.
When comparing patients versus control subjects, the researchers found that only two of the 51 cytokines they measured were different. Tumor growth factor beta was higher and resistin was lower in ME/CFS patients. However, the investigators found that the concentrations of 17 of the cytokines tracked disease severity. Thirteen of those 17 cytokines are pro-inflammatory.
TGF-beta is often thought of as an anti-inflammatory rather than a pro-inflammatory cytokine. But it’s known to take on a pro-inflammatory character in some cases, including certain cancers. ME/CFS patients have a higher than normal incidence of lymphoma, and Montoya speculated that TGF-beta’s elevation in ME/CFS patients could turn out to be a link.
One of the cytokines whose levels corresponded to disease severity, leptin, is secreted by fat tissue. Best known as a satiety reporter that tells the brain when somebody’s stomach is full, leptin is also an active pro-inflammatory substance. Generally, leptin is more abundant in women’s blood than in men’s, which could throw light on why more women than men have ME/CFS.
More generally speaking, the study’s results hold implications for the design of future studies of disease, including clinical trials testing immunomodulatory drugs’ potential as ME/CFS therapies.
“For decades, the ‘case vs. healthy controls’ study design has served well to advance our understanding of many diseases,” Montoya said. “However, it’s possible that for certain pathologies in humans, analysis by disease severity or duration would be likely to provide further insights.”
Other Stanford co-authors of the study are clinical research coordinator Jill Anderson; Tyson Holmes, PhD, senior research engineer at the Institute for Immunity, Transplantation and Infection; Yael Rosenberg-Hasson, PhD, immunoassay and technical director at the institute; Cristina Tato, PhD, MPH, research and science analyst at the institute; former study coordinator Ian Valencia; and Lily Chu, MSHS, a board member of the Stanford University ME/CFS Initiative.
Learn more:Researchers identify biomarkers associated with chronic fatigue syndrome severity
The Latest on: Chronic fatigue syndrome
[google_news title=”” keyword=”chronic fatigue syndrome” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- I’m a GP – the way chronic fatigue patients are treated is unforgivableon March 27, 2024 at 11:01 pm
Many people living with chronic fatigue will often report feeling dismissed or not taken seriously by those around them. They feel unsupported and such feelings trigger poor mental health which in ...
- Terre Haute doctor takes a run at chronic fatigue syndromeon March 27, 2024 at 5:44 pm
Brown, who recently created Grounded Serpent Family Practice, is seeing patients suffering from chronic fatigue syndrome, a malady that long COVID is a subset of. Chronic fatigue syndrome is a mystery ...
- When Is Chronic Fatigue Syndrome Most Likely To Develop? A Review By Doctorson March 27, 2024 at 2:28 pm
Expert opinion from Sai Kiran Kumar K MBBS, MD · 9 years of experience · India Chronic fatigue syndrome most likely can develop at young to middle-aged. Women are most often diagnosed with fatigue ...
- Chronic Fatigue Syndrome and Fibromyalgia in Diagnosed Sleep Disorders: A Further Test of the 'Unitary' Hypothesison March 25, 2024 at 5:00 pm
A substantial number of patients with sleep disturbed breathing fulfill criteria for the diagnosis of chronic fatigue syndrome, but not for fibromyalgia. In contrast, patients with insomnia ...
- People With Chronic Fatigue Syndrome Should Take this Condition Seriously, Researchers Sayon March 25, 2024 at 6:22 am
A simple feeling of tiredness is often neglected and mistook as a normal condition. Still, the latest study about chronic fatigue syndrome says that there's a deeper factor that should be taken ...
- Landmark Study Confirms Chronic Fatigue Syndrome Is 'Unambiguously Biological'on March 23, 2024 at 3:31 pm
In 2016, years before long COVID was a thing, the US National Institutes of Health, the largest single public funder of medical research in the world, launched a study into a long-neglected and ...
- Chronic Fatigue Syndrome: Implications for Women and Their Health Care Providers During the Childbearing Yearson March 21, 2024 at 5:00 pm
"We still have no definitive idea of the risks involved in pregnancy for women with chronic fatigue syndrome. The suggestion that it's okay to be pregnant is not yet substantiated by science.
- Antidepressants Could Trigger Some Cases of Chronic Fatigue Syndromeon March 19, 2024 at 3:00 pm
Long overdue and sorely needed, research into chronic fatigue syndrome has picked up speed since the pandemic illuminated the lasting and debilitating effects of long COVID.
- A Former Pro Climber On Enduring Chronic Illnesson March 19, 2024 at 12:00 am
After years of scaling cliffs for a living, Mason Earle was diagnosed with ME/CFS, commonly called chronic fatigue syndrome. If you can't access your feeds, please contact customer support. Thanks!
- Dr. Oz offers possible explanations for constant fatigueon March 18, 2024 at 6:00 pm
I’m dragging around with no energy these days. I never used to feel this way. What could cause me to be so tired all the time?
via Google News and Bing News